Leadless pacemaker outcomes and follow-up at University Hospital St. Pölten

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center registry prospectively and retrospectively collects data on all leadless pacemaker implantations performed at University Hospital St. Pölten, including demographic information, implantation indications, procedural details, and follow-up findings. Data from patients implanted since 2015 (retrospective inclusion) and from new implantations (prospective inclusion) will be captured, and patients will be invited to participate at routine clinic visits. The registry will record acute, medium-, and long-term complications and will include analysis of novel atrial mechanical sensing markers for which long-term experience is limited. No investigational interventions are performed as part of the registry; it is observational and based on routine clinical care and follow-up visits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing implantation of a leadless pacemaker at the University Hospital of St. Pölten
* Patients who previously received a leadless pacemaker between June 2015 and the start of the registry (retrospective inclusion).
* Age ≥ 18 years.
* Written informed consent provided by the patient.

Exclusion Criteria:

* Patients who decline or are unable to provide informed consent.
* Patients in whom a conventional transvenous pacemaker is implanted (i.e., not leadless).
* Any condition that, in the opinion of the treating physician, precludes participation in the registry.

Where it's running

• University Hospital of St. Pölten
  Sankt Pölten, Lower Austria, Austria Recruiting

Study contacts

• Principal investigator: Julia Mascherbauer, MD, Professor — Department of Internal Medicine III, University Hospital of St. Pölten
• Study coordinator: Matthias Granner, MD
• Email: matthias.granner@stpoelten.lknoe.at
• Phone: +432742900422632

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation

  This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07793916

• Higher pacemaker rate for people with cardiac amyloidosis

  This study will see if temporarily increasing the pacemaker rate improves heart-failure symptoms and exercise tolerance in adults with cardiac amyloidosis who already have pacemakers.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07583823

• Lead-related tricuspid valve leakage after first-time pacemaker or ICD implantation

  This project will see if a new transvenous pacemaker or ICD lead causes new or worse tricuspid valve regurgitation in people getting their first device.

  Recruiting Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW · Bad Oeynhausen, North Rhine-Westphalia · NCT07342036

• Left bundle branch area pacing versus conventional right‑ventricular pacing after TAVI for atrioventricular block

  This will test whether left bundle branch area pacing works better than standard right‑ventricular pacing for people who need a pacemaker after TAVI.

  Recruiting at 6 sites Nantes University Hospital · Brest, Finistère and 6 other locations · NCT07236489

• LivIQ leadless pacemaker system for ventricular pacing

  This trial will test the LivIQ leadless pacemaker in adults who need ventricular pacing (VVI or VDD) to see if it is safe and maintains appropriate heart rhythm and AV timing.

  Recruiting at 41 sites Biotronik, Inc. · Burlingame, California and 42 other locations · NCT07118358

• Aveir Leadless Dual-Chamber Pacemaker Post-Marketing Surveillance in Japan

  This project will collect safety information on the Aveir DR leadless pacemaker for patients in Japan who need new dual-chamber pacing, upgrades from single-chamber devices, or who rolled over from an earlier Aveir trial.

  Recruiting at 14 sites Abbott Medical Devices · Nagoya, Aichi-ken and 13 other locations · NCT07106788

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.